Paulson & Co. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$251,000
-12.2%
70,8000.0%0.00%0.0%
Q3 2016$286,000
-8.0%
70,8000.0%0.00%0.0%
Q2 2016$311,000
+16.0%
70,8000.0%0.00%
+50.0%
Q1 2016$268,00070,8000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,000$1,359,000100.00%
TSP Capital Management Group, LLC 236,919$1,197,0000.67%
Meditor Group Ltd 6,312,700$1,249,0000.26%
Anson Funds Management LP 1,229,844$243,0000.14%
Cresset Asset Management, LLC 6,865,000$1,359,0000.08%
Telemetry Investments, L.L.C. 348,501$69,0000.04%
GSA CAPITAL PARTNERS LLP 789,260$156,0000.02%
Benchmark Capital Advisors 32,600$6,0000.01%
BOENNING & SCATTERGOOD, INC. 74,950$15,0000.01%
Stratos Wealth Partners, LTD. 250,000$49,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders